Hindutva extremists attack Muslim cop, attempt to shave his beard

Bengaluru, Feb 14: After the swearing-in of ten former JDS and Congress MLAs, political boundaries seem to have become more fluid, with little clarity on who is on whose side. When Honnali BJP MLA Renukacharya visited senior Congressman DK Shivakumar at the latter’s residence, many eyebrows were raised over the reason behind the meeting. There was speculation over why Renukacharya would be meeting a man who is, in all likelihood, slated to be the next KPCC president.

Renukacharya reacted to the rumours by making the meet sound purely professional. He said, “We have a three-day Krushi Sammlan in Honnali, and I went to invite him (DKS) for it.’’   Shivakumar also remained tight-lipped over the real reason behind the meeting, and corroborated Renukacharya’s story. However, insiders claim that the two discussed other issues too. It may be recalled that Renukacharya had openly rebelled against Yediyurappa in 2009.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Bengaluru, Jul 12: KCTET 2020: Attention candidates, the Karnataka Deputy Chief Minister has confirmed the exam dates for Karnataka Common Entrance Test, KCET 2020.

As per information, KCET 2020 will be held between July 30 and July 31.

Karnataka Common Entrance Test or KCET is an examination which is held for admission to BTech courses in the state’s institutes.

The Higher Education Minister C N Ashwathnarayan, took to twitter to confirm the KCET dates. The Minister tweeted:

“The K-CET 2020 examinations will be held on the decided dates of July 30 & July 31. All the best to all the students!”

Details regarding KCET exam centers, time, and schedule will be mentioned in the admit card. Candidates can download their admit card fro the official website of KEA i.e. cetonline.karnataka.gov.in.

KCET 2020 was earlier scheduled to be held from April 22 to April 24, 2020, however, due to the ongoing coronavirus outbreak, KEA postponed KCET 2020 exams.